Modulation of Gut Microbiome and Metabolome as One of the Potential Mechanisms of Ketogenic Diet Effect in the Treatment of Epilepsy
Nutrients · 2025
DOI: 10.3390/nu18010031 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2025. Verfasst von Katarzyna Kowalcze und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health Sciences, Faculty of Medical and Health Sciences, University of Siedlce, 08-110 Siedlce, Poland. Hauptthemen laut MEDLINE: Diet, Ketogenic, Gastrointestinal Microbiome, Epilepsy, Metabolome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Siedlce, Institute of Health Sciences, Faculty of Medical and Health Sciences, University of Siedlce.
Abstract (Originalsprache)
Background/Objectives: The over 100-year-old practice of using ketogenic diet (KD) in the treatment of epilepsy has consolidated its position as an effective therapeutic tool. The available publications suggest a significant influence of KD on gut microbiome and metabolome and, on the other hand, a correlation between microbiome and metabolome changes and the course of epilepsy. The conclusion is therefore justified that KD can exert a therapeutic effect in epilepsy through the mechanism of gut microbiome and metabolome modulation. Methods:This article is a narrative review aimed at a comprehensive analysis of the literature to gather existing evidence on the relationship between ketogenic diet, its antiepileptic effects and modulation of gut microbiome and metabolome.
Results
It has been demonstrated that a ketogenic diet exerts a significant effect on intestinal bacteria and their metabolites, among other actions, increasing the Bacteroides to Firmicutes (B/F) ratio, alleviating dysbiosis, reducing the inflammatory condition in the gut and whole body, increasing the number of specific strains associated with antiepileptic effect, mediating the production of neurotransmitters (GABA, serotonin), exerting influence on the dopaminergic system, on a number of metabolic pathways, on inhibition of genotoxicity and production of short-chain fatty acids (SCFA) in the intestine.
Conclusions
Further studies are needed, since the effect of KD on gut microbiome and metabolome modulation in the treatment of epilepsy is an extremely promising and trendsetting direction of research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Health Sciences, Faculty of Medical and Health Sciences, University of Siedlce, 08-110 Siedlce, Poland.
- Sirene Medical Clinic, 02-796 Warszawa, Poland.
- Warsaw Genomics S.A., 02-089 Warsaw, Poland.
- Pediatric Neurology Department, Chorzow General Hospital, 41-500 Chorzów, Poland.
ORCID-Profile: Katarzyna Kowalcze, Wiktoria Klus, Magdalena Dudzińska, Agnieszka Paziewska
Förderung
- University of Siedlce
- Institute of Health Sciences, Faculty of Medical and Health Sciences, University of Siedlce
Zitieren
APA
Kowalcze, K., Dyńka, D., Klus, W., Dudzińska, M., & Paziewska, A. (2025). Modulation of Gut Microbiome and Metabolome as One of the Potential Mechanisms of Ketogenic Diet Effect in the Treatment of Epilepsy. Nutrients. https://doi.org/10.3390/nu18010031
Vancouver
Kowalcze K, Dyńka D, Klus W, Dudzińska M, Paziewska A. Modulation of Gut Microbiome and Metabolome as One of the Potential Mechanisms of Ketogenic Diet Effect in the Treatment of Epilepsy. Nutrients. 2025. doi:10.3390/nu18010031
BibTeX
@article{Kowalcze2025,
author = {Kowalcze, Katarzyna and Dyńka, Damian and Klus, Wiktoria and Dudzińska, Magdalena and Paziewska, Agnieszka},
title = {Modulation of Gut Microbiome and Metabolome as One of the Potential Mechanisms of Ketogenic Diet Effect in the Treatment of Epilepsy},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu18010031}
}
EUVIMED